Global Dermal Fillers and Botulinum Toxin Market Growth 2022-2028
As the global economy mends, the 2021 growth of Dermal Fillers and Botulinum Toxin will have significant change from previous year. According to our latest study, the global Dermal Fillers and Botulinum Toxin market size is USD million in 2022 from USD 11790 million in 2021, with a change of % between 2021 and 2022. The global Dermal Fillers and Botulinum Toxin market size will reach USD 30850 million in 2028, growing at a CAGR of 14.7% over the analysis period.
The United States Dermal Fillers and Botulinum Toxin market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Dermal Fillers and Botulinum Toxin market, reaching US$ million by the year 2028. As for the Europe Dermal Fillers and Botulinum Toxin landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Dermal Fillers and Botulinum Toxin players cover Allergan, Galderma, LG Life Science, and Merz, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Dermal Fillers and Botulinum Toxin market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Dermal Fillers
Botulinum Toxin
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Medical
Cosmetic
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Allergan
Galderma
LG Life Science
Merz
Medytox
Bloomage
Bohus BioTech
Sinclair Pharma
IMEIK
Suneva Medical
Teoxane
Luminera
SciVision Biotech
Haohai Bio
Ipsen
LIBP
US World Meds
Hugel
Daewoong
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Dermal Fillers and Botulinum Toxin Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Dermal Fillers and Botulinum Toxin by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Dermal Fillers and Botulinum Toxin by Country/Region, 2017, 2022 & 2028
2.2 Dermal Fillers and Botulinum Toxin Segment by Type
2.2.1 Dermal Fillers
2.2.2 Botulinum Toxin
2.3 Dermal Fillers and Botulinum Toxin Sales by Type
2.3.1 Global Dermal Fillers and Botulinum Toxin Sales Market Share by Type (2017-2022)
2.3.2 Global Dermal Fillers and Botulinum Toxin Revenue and Market Share by Type (2017-2022)
2.3.3 Global Dermal Fillers and Botulinum Toxin Sale Price by Type (2017-2022)
2.4 Dermal Fillers and Botulinum Toxin Segment by Application
2.4.1 Medical
2.4.2 Cosmetic
2.5 Dermal Fillers and Botulinum Toxin Sales by Application
2.5.1 Global Dermal Fillers and Botulinum Toxin Sale Market Share by Application (2017-2022)
2.5.2 Global Dermal Fillers and Botulinum Toxin Revenue and Market Share by Application (2017-2022)
2.5.3 Global Dermal Fillers and Botulinum Toxin Sale Price by Application (2017-2022)
3 Global Dermal Fillers and Botulinum Toxin by Company
3.1 Global Dermal Fillers and Botulinum Toxin Breakdown Data by Company
3.1.1 Global Dermal Fillers and Botulinum Toxin Annual Sales by Company (2020-2022)
3.1.2 Global Dermal Fillers and Botulinum Toxin Sales Market Share by Company (2020-2022)
3.2 Global Dermal Fillers and Botulinum Toxin Annual Revenue by Company (2020-2022)
3.2.1 Global Dermal Fillers and Botulinum Toxin Revenue by Company (2020-2022)
3.2.2 Global Dermal Fillers and Botulinum Toxin Revenue Market Share by Company (2020-2022)
3.3 Global Dermal Fillers and Botulinum Toxin Sale Price by Company
3.4 Key Manufacturers Dermal Fillers and Botulinum Toxin Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Dermal Fillers and Botulinum Toxin Product Location Distribution
3.4.2 Players Dermal Fillers and Botulinum Toxin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Dermal Fillers and Botulinum Toxin by Geographic Region
4.1 World Historic Dermal Fillers and Botulinum Toxin Market Size by Geographic Region (2017-2022)
4.1.1 Global Dermal Fillers and Botulinum Toxin Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Dermal Fillers and Botulinum Toxin Annual Revenue by Geographic Region
4.2 World Historic Dermal Fillers and Botulinum Toxin Market Size by Country/Region (2017-2022)
4.2.1 Global Dermal Fillers and Botulinum Toxin Annual Sales by Country/Region (2017-2022)
4.2.2 Global Dermal Fillers and Botulinum Toxin Annual Revenue by Country/Region
4.3 Americas Dermal Fillers and Botulinum Toxin Sales Growth
4.4 APAC Dermal Fillers and Botulinum Toxin Sales Growth
4.5 Europe Dermal Fillers and Botulinum Toxin Sales Growth
4.6 Middle East & Africa Dermal Fillers and Botulinum Toxin Sales Growth
5 Americas
5.1 Americas Dermal Fillers and Botulinum Toxin Sales by Country
5.1.1 Americas Dermal Fillers and Botulinum Toxin Sales by Country (2017-2022)
5.1.2 Americas Dermal Fillers and Botulinum Toxin Revenue by Country (2017-2022)
5.2 Americas Dermal Fillers and Botulinum Toxin Sales by Type
5.3 Americas Dermal Fillers and Botulinum Toxin Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Dermal Fillers and Botulinum Toxin Sales by Region
6.1.1 APAC Dermal Fillers and Botulinum Toxin Sales by Region (2017-2022)
6.1.2 APAC Dermal Fillers and Botulinum Toxin Revenue by Region (2017-2022)
6.2 APAC Dermal Fillers and Botulinum Toxin Sales by Type
6.3 APAC Dermal Fillers and Botulinum Toxin Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Dermal Fillers and Botulinum Toxin by Country
7.1.1 Europe Dermal Fillers and Botulinum Toxin Sales by Country (2017-2022)
7.1.2 Europe Dermal Fillers and Botulinum Toxin Revenue by Country (2017-2022)
7.2 Europe Dermal Fillers and Botulinum Toxin Sales by Type
7.3 Europe Dermal Fillers and Botulinum Toxin Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Dermal Fillers and Botulinum Toxin by Country
8.1.1 Middle East & Africa Dermal Fillers and Botulinum Toxin Sales by Country (2017-2022)
8.1.2 Middle East & Africa Dermal Fillers and Botulinum Toxin Revenue by Country (2017-2022)
8.2 Middle East & Africa Dermal Fillers and Botulinum Toxin Sales by Type
8.3 Middle East & Africa Dermal Fillers and Botulinum Toxin Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Dermal Fillers and Botulinum Toxin
10.3 Manufacturing Process Analysis of Dermal Fillers and Botulinum Toxin
10.4 Industry Chain Structure of Dermal Fillers and Botulinum Toxin
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Dermal Fillers and Botulinum Toxin Distributors
11.3 Dermal Fillers and Botulinum Toxin Customer
12 World Forecast Review for Dermal Fillers and Botulinum Toxin by Geographic Region
12.1 Global Dermal Fillers and Botulinum Toxin Market Size Forecast by Region
12.1.1 Global Dermal Fillers and Botulinum Toxin Forecast by Region (2023-2028)
12.1.2 Global Dermal Fillers and Botulinum Toxin Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Dermal Fillers and Botulinum Toxin Forecast by Type
12.7 Global Dermal Fillers and Botulinum Toxin Forecast by Application
13 Key Players Analysis
13.1 Allergan
13.1.1 Allergan Company Information
13.1.2 Allergan Dermal Fillers and Botulinum Toxin Product Offered
13.1.3 Allergan Dermal Fillers and Botulinum Toxin Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Allergan Main Business Overview
13.1.5 Allergan Latest Developments
13.2 Galderma
13.2.1 Galderma Company Information
13.2.2 Galderma Dermal Fillers and Botulinum Toxin Product Offered
13.2.3 Galderma Dermal Fillers and Botulinum Toxin Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Galderma Main Business Overview
13.2.5 Galderma Latest Developments
13.3 LG Life Science
13.3.1 LG Life Science Company Information
13.3.2 LG Life Science Dermal Fillers and Botulinum Toxin Product Offered
13.3.3 LG Life Science Dermal Fillers and Botulinum Toxin Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 LG Life Science Main Business Overview
13.3.5 LG Life Science Latest Developments
13.4 Merz
13.4.1 Merz Company Information
13.4.2 Merz Dermal Fillers and Botulinum Toxin Product Offered
13.4.3 Merz Dermal Fillers and Botulinum Toxin Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Merz Main Business Overview
13.4.5 Merz Latest Developments
13.5 Medytox
13.5.1 Medytox Company Information
13.5.2 Medytox Dermal Fillers and Botulinum Toxin Product Offered
13.5.3 Medytox Dermal Fillers and Botulinum Toxin Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Medytox Main Business Overview
13.5.5 Medytox Latest Developments
13.6 Bloomage
13.6.1 Bloomage Company Information
13.6.2 Bloomage Dermal Fillers and Botulinum Toxin Product Offered
13.6.3 Bloomage Dermal Fillers and Botulinum Toxin Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Bloomage Main Business Overview
13.6.5 Bloomage Latest Developments
13.7 Bohus BioTech
13.7.1 Bohus BioTech Company Information
13.7.2 Bohus BioTech Dermal Fillers and Botulinum Toxin Product Offered
13.7.3 Bohus BioTech Dermal Fillers and Botulinum Toxin Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Bohus BioTech Main Business Overview
13.7.5 Bohus BioTech Latest Developments
13.8 Sinclair Pharma
13.8.1 Sinclair Pharma Company Information
13.8.2 Sinclair Pharma Dermal Fillers and Botulinum Toxin Product Offered
13.8.3 Sinclair Pharma Dermal Fillers and Botulinum Toxin Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Sinclair Pharma Main Business Overview
13.8.5 Sinclair Pharma Latest Developments
13.9 IMEIK
13.9.1 IMEIK Company Information
13.9.2 IMEIK Dermal Fillers and Botulinum Toxin Product Offered
13.9.3 IMEIK Dermal Fillers and Botulinum Toxin Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 IMEIK Main Business Overview
13.9.5 IMEIK Latest Developments
13.10 Suneva Medical
13.10.1 Suneva Medical Company Information
13.10.2 Suneva Medical Dermal Fillers and Botulinum Toxin Product Offered
13.10.3 Suneva Medical Dermal Fillers and Botulinum Toxin Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Suneva Medical Main Business Overview
13.10.5 Suneva Medical Latest Developments
13.11 Teoxane
13.11.1 Teoxane Company Information
13.11.2 Teoxane Dermal Fillers and Botulinum Toxin Product Offered
13.11.3 Teoxane Dermal Fillers and Botulinum Toxin Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Teoxane Main Business Overview
13.11.5 Teoxane Latest Developments
13.12 Luminera
13.12.1 Luminera Company Information
13.12.2 Luminera Dermal Fillers and Botulinum Toxin Product Offered
13.12.3 Luminera Dermal Fillers and Botulinum Toxin Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Luminera Main Business Overview
13.12.5 Luminera Latest Developments
13.13 SciVision Biotech
13.13.1 SciVision Biotech Company Information
13.13.2 SciVision Biotech Dermal Fillers and Botulinum Toxin Product Offered
13.13.3 SciVision Biotech Dermal Fillers and Botulinum Toxin Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 SciVision Biotech Main Business Overview
13.13.5 SciVision Biotech Latest Developments
13.14 Haohai Bio
13.14.1 Haohai Bio Company Information
13.14.2 Haohai Bio Dermal Fillers and Botulinum Toxin Product Offered
13.14.3 Haohai Bio Dermal Fillers and Botulinum Toxin Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Haohai Bio Main Business Overview
13.14.5 Haohai Bio Latest Developments
13.15 Ipsen
13.15.1 Ipsen Company Information
13.15.2 Ipsen Dermal Fillers and Botulinum Toxin Product Offered
13.15.3 Ipsen Dermal Fillers and Botulinum Toxin Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Ipsen Main Business Overview
13.15.5 Ipsen Latest Developments
13.16 LIBP
13.16.1 LIBP Company Information
13.16.2 LIBP Dermal Fillers and Botulinum Toxin Product Offered
13.16.3 LIBP Dermal Fillers and Botulinum Toxin Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 LIBP Main Business Overview
13.16.5 LIBP Latest Developments
13.17 US World Meds
13.17.1 US World Meds Company Information
13.17.2 US World Meds Dermal Fillers and Botulinum Toxin Product Offered
13.17.3 US World Meds Dermal Fillers and Botulinum Toxin Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 US World Meds Main Business Overview
13.17.5 US World Meds Latest Developments
13.18 Hugel
13.18.1 Hugel Company Information
13.18.2 Hugel Dermal Fillers and Botulinum Toxin Product Offered
13.18.3 Hugel Dermal Fillers and Botulinum Toxin Sales, Revenue, Price and Gross Margin (2020-2022)
13.18.4 Hugel Main Business Overview
13.18.5 Hugel Latest Developments
13.19 Daewoong
13.19.1 Daewoong Company Information
13.19.2 Daewoong Dermal Fillers and Botulinum Toxin Product Offered
13.19.3 Daewoong Dermal Fillers and Botulinum Toxin Sales, Revenue, Price and Gross Margin (2020-2022)
13.19.4 Daewoong Main Business Overview
13.19.5 Daewoong Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Dermal Fillers and Botulinum Toxin Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Dermal Fillers and Botulinum Toxin Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Dermal Fillers
Table 4. Major Players of Botulinum Toxin
Table 5. Global Dermal Fillers and Botulinum Toxin Sales by Type (2017-2022) & (K Units)
Table 6. Global Dermal Fillers and Botulinum Toxin Sales Market Share by Type (2017-2022)
Table 7. Global Dermal Fillers and Botulinum Toxin Revenue by Type (2017-2022) & ($ million)
Table 8. Global Dermal Fillers and Botulinum Toxin Revenue Market Share by Type (2017-2022)
Table 9. Global Dermal Fillers and Botulinum Toxin Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Dermal Fillers and Botulinum Toxin Sales by Application (2017-2022) & (K Units)
Table 11. Global Dermal Fillers and Botulinum Toxin Sales Market Share by Application (2017-2022)
Table 12. Global Dermal Fillers and Botulinum Toxin Revenue by Application (2017-2022)
Table 13. Global Dermal Fillers and Botulinum Toxin Revenue Market Share by Application (2017-2022)
Table 14. Global Dermal Fillers and Botulinum Toxin Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Dermal Fillers and Botulinum Toxin Sales by Company (2020-2022) & (K Units)
Table 16. Global Dermal Fillers and Botulinum Toxin Sales Market Share by Company (2020-2022)
Table 17. Global Dermal Fillers and Botulinum Toxin Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Dermal Fillers and Botulinum Toxin Revenue Market Share by Company (2020-2022)
Table 19. Global Dermal Fillers and Botulinum Toxin Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Dermal Fillers and Botulinum Toxin Producing Area Distribution and Sales Area
Table 21. Players Dermal Fillers and Botulinum Toxin Products Offered
Table 22. Dermal Fillers and Botulinum Toxin Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Dermal Fillers and Botulinum Toxin Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Dermal Fillers and Botulinum Toxin Sales Market Share Geographic Region (2017-2022)
Table 27. Global Dermal Fillers and Botulinum Toxin Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Dermal Fillers and Botulinum Toxin Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Dermal Fillers and Botulinum Toxin Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Dermal Fillers and Botulinum Toxin Sales Market Share by Country/Region (2017-2022)
Table 31. Global Dermal Fillers and Botulinum Toxin Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Dermal Fillers and Botulinum Toxin Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Dermal Fillers and Botulinum Toxin Sales by Country (2017-2022) & (K Units)
Table 34. Americas Dermal Fillers and Botulinum Toxin Sales Market Share by Country (2017-2022)
Table 35. Americas Dermal Fillers and Botulinum Toxin Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Dermal Fillers and Botulinum Toxin Revenue Market Share by Country (2017-2022)
Table 37. Americas Dermal Fillers and Botulinum Toxin Sales by Type (2017-2022) & (K Units)
Table 38. Americas Dermal Fillers and Botulinum Toxin Sales Market Share by Type (2017-2022)
Table 39. Americas Dermal Fillers and Botulinum Toxin Sales by Application (2017-2022) & (K Units)
Table 40. Americas Dermal Fillers and Botulinum Toxin Sales Market Share by Application (2017-2022)
Table 41. APAC Dermal Fillers and Botulinum Toxin Sales by Region (2017-2022) & (K Units)
Table 42. APAC Dermal Fillers and Botulinum Toxin Sales Market Share by Region (2017-2022)
Table 43. APAC Dermal Fillers and Botulinum Toxin Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Dermal Fillers and Botulinum Toxin Revenue Market Share by Region (2017-2022)
Table 45. APAC Dermal Fillers and Botulinum Toxin Sales by Type (2017-2022) & (K Units)
Table 46. APAC Dermal Fillers and Botulinum Toxin Sales Market Share by Type (2017-2022)
Table 47. APAC Dermal Fillers and Botulinum Toxin Sales by Application (2017-2022) & (K Units)
Table 48. APAC Dermal Fillers and Botulinum Toxin Sales Market Share by Application (2017-2022)
Table 49. Europe Dermal Fillers and Botulinum Toxin Sales by Country (2017-2022) & (K Units)
Table 50. Europe Dermal Fillers and Botulinum Toxin Sales Market Share by Country (2017-2022)
Table 51. Europe Dermal Fillers and Botulinum Toxin Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Dermal Fillers and Botulinum Toxin Revenue Market Share by Country (2017-2022)
Table 53. Europe Dermal Fillers and Botulinum Toxin Sales by Type (2017-2022) & (K Units)
Table 54. Europe Dermal Fillers and Botulinum Toxin Sales Market Share by Type (2017-2022)
Table 55. Europe Dermal Fillers and Botulinum Toxin Sales by Application (2017-2022) & (K Units)
Table 56. Europe Dermal Fillers and Botulinum Toxin Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Dermal Fillers and Botulinum Toxin Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Dermal Fillers and Botulinum Toxin Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Dermal Fillers and Botulinum Toxin Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Dermal Fillers and Botulinum Toxin Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Dermal Fillers and Botulinum Toxin Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Dermal Fillers and Botulinum Toxin Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Dermal Fillers and Botulinum Toxin Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Dermal Fillers and Botulinum Toxin Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Dermal Fillers and Botulinum Toxin
Table 66. Key Market Challenges & Risks of Dermal Fillers and Botulinum Toxin
Table 67. Key Industry Trends of Dermal Fillers and Botulinum Toxin
Table 68. Dermal Fillers and Botulinum Toxin Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Dermal Fillers and Botulinum Toxin Distributors List
Table 71. Dermal Fillers and Botulinum Toxin Customer List
Table 72. Global Dermal Fillers and Botulinum Toxin Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Dermal Fillers and Botulinum Toxin Sales Market Forecast by Region
Table 74. Global Dermal Fillers and Botulinum Toxin Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Dermal Fillers and Botulinum Toxin Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Dermal Fillers and Botulinum Toxin Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Dermal Fillers and Botulinum Toxin Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Dermal Fillers and Botulinum Toxin Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Dermal Fillers and Botulinum Toxin Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Dermal Fillers and Botulinum Toxin Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Dermal Fillers and Botulinum Toxin Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Dermal Fillers and Botulinum Toxin Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Dermal Fillers and Botulinum Toxin Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Dermal Fillers and Botulinum Toxin Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Dermal Fillers and Botulinum Toxin Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Dermal Fillers and Botulinum Toxin Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Dermal Fillers and Botulinum Toxin Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Dermal Fillers and Botulinum Toxin Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Dermal Fillers and Botulinum Toxin Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Dermal Fillers and Botulinum Toxin Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Dermal Fillers and Botulinum Toxin Revenue Market Share Forecast by Application (2023-2028)
Table 92. Allergan Basic Information, Dermal Fillers and Botulinum Toxin Manufacturing Base, Sales Area and Its Competitors
Table 93. Allergan Dermal Fillers and Botulinum Toxin Product Offered
Table 94. Allergan Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. Allergan Main Business
Table 96. Allergan Latest Developments
Table 97. Galderma Basic Information, Dermal Fillers and Botulinum Toxin Manufacturing Base, Sales Area and Its Competitors
Table 98. Galderma Dermal Fillers and Botulinum Toxin Product Offered
Table 99. Galderma Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. Galderma Main Business
Table 101. Galderma Latest Developments
Table 102. LG Life Science Basic Information, Dermal Fillers and Botulinum Toxin Manufacturing Base, Sales Area and Its Competitors
Table 103. LG Life Science Dermal Fillers and Botulinum Toxin Product Offered
Table 104. LG Life Science Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. LG Life Science Main Business
Table 106. LG Life Science Latest Developments
Table 107. Merz Basic Information, Dermal Fillers and Botulinum Toxin Manufacturing Base, Sales Area and Its Competitors
Table 108. Merz Dermal Fillers and Botulinum Toxin Product Offered
Table 109. Merz Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Merz Main Business
Table 111. Merz Latest Developments
Table 112. Medytox Basic Information, Dermal Fillers and Botulinum Toxin Manufacturing Base, Sales Area and Its Competitors
Table 113. Medytox Dermal Fillers and Botulinum Toxin Product Offered
Table 114. Medytox Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. Medytox Main Business
Table 116. Medytox Latest Developments
Table 117. Bloomage Basic Information, Dermal Fillers and Botulinum Toxin Manufacturing Base, Sales Area and Its Competitors
Table 118. Bloomage Dermal Fillers and Botulinum Toxin Product Offered
Table 119. Bloomage Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. Bloomage Main Business
Table 121. Bloomage Latest Developments
Table 122. Bohus BioTech Basic Information, Dermal Fillers and Botulinum Toxin Manufacturing Base, Sales Area and Its Competitors
Table 123. Bohus BioTech Dermal Fillers and Botulinum Toxin Product Offered
Table 124. Bohus BioTech Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. Bohus BioTech Main Business
Table 126. Bohus BioTech Latest Developments
Table 127. Sinclair Pharma Basic Information, Dermal Fillers and Botulinum Toxin Manufacturing Base, Sales Area and Its Competitors
Table 128. Sinclair Pharma Dermal Fillers and Botulinum Toxin Product Offered
Table 129. Sinclair Pharma Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 130. Sinclair Pharma Main Business
Table 131. Sinclair Pharma Latest Developments
Table 132. IMEIK Basic Information, Dermal Fillers and Botulinum Toxin Manufacturing Base, Sales Area and Its Competitors
Table 133. IMEIK Dermal Fillers and Botulinum Toxin Product Offered
Table 134. IMEIK Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 135. IMEIK Main Business
Table 136. IMEIK Latest Developments
Table 137. Suneva Medical Basic Information, Dermal Fillers and Botulinum Toxin Manufacturing Base, Sales Area and Its Competitors
Table 138. Suneva Medical Dermal Fillers and Botulinum Toxin Product Offered
Table 139. Suneva Medical Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 140. Suneva Medical Main Business
Table 141. Suneva Medical Latest Developments
Table 142. Teoxane Basic Information, Dermal Fillers and Botulinum Toxin Manufacturing Base, Sales Area and Its Competitors
Table 143. Teoxane Dermal Fillers and Botulinum Toxin Product Offered
Table 144. Teoxane Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 145. Teoxane Main Business
Table 146. Teoxane Latest Developments
Table 147. Luminera Basic Information, Dermal Fillers and Botulinum Toxin Manufacturing Base, Sales Area and Its Competitors
Table 148. Luminera Dermal Fillers and Botulinum Toxin Product Offered
Table 149. Luminera Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 150. Luminera Main Business
Table 151. Luminera Latest Developments
Table 152. SciVision Biotech Basic Information, Dermal Fillers and Botulinum Toxin Manufacturing Base, Sales Area and Its Competitors
Table 153. SciVision Biotech Dermal Fillers and Botulinum Toxin Product Offered
Table 154. SciVision Biotech Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 155. SciVision Biotech Main Business
Table 156. SciVision Biotech Latest Developments
Table 157. Haohai Bio Basic Information, Dermal Fillers and Botulinum Toxin Manufacturing Base, Sales Area and Its Competitors
Table 158. Haohai Bio Dermal Fillers and Botulinum Toxin Product Offered
Table 159. Haohai Bio Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 160. Haohai Bio Main Business
Table 161. Haohai Bio Latest Developments
Table 162. Ipsen Basic Information, Dermal Fillers and Botulinum Toxin Manufacturing Base, Sales Area and Its Competitors
Table 163. Ipsen Dermal Fillers and Botulinum Toxin Product Offered
Table 164. Ipsen Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 165. Ipsen Main Business
Table 166. Ipsen Latest Developments
Table 167. LIBP Basic Information, Dermal Fillers and Botulinum Toxin Manufacturing Base, Sales Area and Its Competitors
Table 168. LIBP Dermal Fillers and Botulinum Toxin Product Offered
Table 169. LIBP Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 170. LIBP Main Business
Table 171. LIBP Latest Developments
Table 172. US World Meds Basic Information, Dermal Fillers and Botulinum Toxin Manufacturing Base, Sales Area and Its Competitors
Table 173. US World Meds Dermal Fillers and Botulinum Toxin Product Offered
Table 174. US World Meds Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 175. US World Meds Main Business
Table 176. US World Meds Latest Developments
Table 177. Hugel Basic Information, Dermal Fillers and Botulinum Toxin Manufacturing Base, Sales Area and Its Competitors
Table 178. Hugel Dermal Fillers and Botulinum Toxin Product Offered
Table 179. Hugel Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 180. Hugel Main Business
Table 181. Hugel Latest Developments
Table 182. Daewoong Basic Information, Dermal Fillers and Botulinum Toxin Manufacturing Base, Sales Area and Its Competitors
Table 183. Daewoong Dermal Fillers and Botulinum Toxin Product Offered
Table 184. Daewoong Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 185. Daewoong Main Business
Table 186. Daewoong Latest Developments
List of Figures
Figure 1. Picture of Dermal Fillers and Botulinum Toxin
Figure 2. Dermal Fillers and Botulinum Toxin Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Dermal Fillers and Botulinum Toxin Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Dermal Fillers and Botulinum Toxin Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Dermal Fillers and Botulinum Toxin Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Dermal Fillers
Figure 10. Product Picture of Botulinum Toxin
Figure 11. Global Dermal Fillers and Botulinum Toxin Sales Market Share by Type in 2021
Figure 12. Global Dermal Fillers and Botulinum Toxin Revenue Market Share by Type (2017-2022)
Figure 13. Dermal Fillers and Botulinum Toxin Consumed in Medical
Figure 14. Global Dermal Fillers and Botulinum Toxin Market: Medical (2017-2022) & (K Units)
Figure 15. Dermal Fillers and Botulinum Toxin Consumed in Cosmetic
Figure 16. Global Dermal Fillers and Botulinum Toxin Market: Cosmetic (2017-2022) & (K Units)
Figure 17. Global Dermal Fillers and Botulinum Toxin Sales Market Share by Application (2017-2022)
Figure 18. Global Dermal Fillers and Botulinum Toxin Revenue Market Share by Application in 2021
Figure 19. Dermal Fillers and Botulinum Toxin Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Dermal Fillers and Botulinum Toxin Revenue Market Share by Company in 2021
Figure 21. Global Dermal Fillers and Botulinum Toxin Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Dermal Fillers and Botulinum Toxin Revenue Market Share by Geographic Region in 2021
Figure 23. Global Dermal Fillers and Botulinum Toxin Sales Market Share by Region (2017-2022)
Figure 24. Global Dermal Fillers and Botulinum Toxin Revenue Market Share by Country/Region in 2021
Figure 25. Americas Dermal Fillers and Botulinum Toxin Sales 2017-2022 (K Units)
Figure 26. Americas Dermal Fillers and Botulinum Toxin Revenue 2017-2022 ($ Millions)
Figure 27. APAC Dermal Fillers and Botulinum Toxin Sales 2017-2022 (K Units)
Figure 28. APAC Dermal Fillers and Botulinum Toxin Revenue 2017-2022 ($ Millions)
Figure 29. Europe Dermal Fillers and Botulinum Toxin Sales 2017-2022 (K Units)
Figure 30. Europe Dermal Fillers and Botulinum Toxin Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Dermal Fillers and Botulinum Toxin Sales 2017-2022 (K Units)
Figure 32. Middle East & Africa Dermal Fillers and Botulinum Toxin Revenue 2017-2022 ($ Millions)
Figure 33. Americas Dermal Fillers and Botulinum Toxin Sales Market Share by Country in 2021
Figure 34. Americas Dermal Fillers and Botulinum Toxin Revenue Market Share by Country in 2021
Figure 35. United States Dermal Fillers and Botulinum Toxin Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Dermal Fillers and Botulinum Toxin Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Dermal Fillers and Botulinum Toxin Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Dermal Fillers and Botulinum Toxin Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Dermal Fillers and Botulinum Toxin Sales Market Share by Region in 2021
Figure 40. APAC Dermal Fillers and Botulinum Toxin Revenue Market Share by Regions in 2021
Figure 41. China Dermal Fillers and Botulinum Toxin Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Dermal Fillers and Botulinum Toxin Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Dermal Fillers and Botulinum Toxin Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Dermal Fillers and Botulinum Toxin Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Dermal Fillers and Botulinum Toxin Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Dermal Fillers and Botulinum Toxin Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Dermal Fillers and Botulinum Toxin Sales Market Share by Country in 2021
Figure 48. Europe Dermal Fillers and Botulinum Toxin Revenue Market Share by Country in 2021
Figure 49. Germany Dermal Fillers and Botulinum Toxin Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Dermal Fillers and Botulinum Toxin Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Dermal Fillers and Botulinum Toxin Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Dermal Fillers and Botulinum Toxin Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Dermal Fillers and Botulinum Toxin Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Dermal Fillers and Botulinum Toxin Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Dermal Fillers and Botulinum Toxin Revenue Market Share by Country in 2021
Figure 56. Egypt Dermal Fillers and Botulinum Toxin Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Dermal Fillers and Botulinum Toxin Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Dermal Fillers and Botulinum Toxin Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Dermal Fillers and Botulinum Toxin Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Dermal Fillers and Botulinum Toxin Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Dermal Fillers and Botulinum Toxin in 2021
Figure 62. Manufacturing Process Analysis of Dermal Fillers and Botulinum Toxin
Figure 63. Industry Chain Structure of Dermal Fillers and Botulinum Toxin
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
